0001209191-15-025334.txt : 20150311
0001209191-15-025334.hdr.sgml : 20150311
20150311183609
ACCESSION NUMBER: 0001209191-15-025334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150309
FILED AS OF DATE: 20150311
DATE AS OF CHANGE: 20150311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ruegg Curtis
CENTRAL INDEX KEY: 0001597578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 15693949
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-03-09
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001597578
Ruegg Curtis
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK
CA
94560
0
1
0
0
EVP, Technical Operations
Common Stock
2015-03-09
4
M
0
500
6.60
A
19837
D
Common Stock
2015-03-09
4
S
0
500
18.00
D
19337
D
Stock Option (Right to Buy)
6.60
2015-03-09
4
M
0
500
0.00
D
2016-05-15
Common Stock
500
3003
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2014.
The Option is fully vested as of May 16, 2010.
/s/ Gordon Ho, Attorney-in-fact
2015-03-11